TCG Crossover Management »

Aerovate Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $65M 2.2M 29.57
2023-12-31 $50M 2.2M 22.63
2023-09-30 $30M 2.2M 13.57
2023-06-30 $38M 2.2M 17.15
2023-03-31 $22M 1.1M 20.17
2022-12-31 $32M 1.1M 29.30
2022-09-30 $16M 960k 16.58
2022-06-30 $14M 890k 15.63
2022-03-31 $16M 890k 18.33
2021-12-31 $10M 853k 11.79